Prof. Dr. Rainer Fietkau

Medizinische Fakultät Lehrstuhl für Strahlentherapie

Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? (2016) Schreiner W, Dudek W, Lettmaier S, Fietkau R, Sirbu H Journal article Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain (2016) Goerig N, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt M, Dörfler A, et al. Journal article Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy (2016) Seibold J, Strnad V, Fietkau R Journal article PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis (2016) Hecht M, Buettner-Herold M, Erlenbach-Wuensch K, Haderlein M, Croner R, Grützmann R, Hartmann A, et al. Journal article Cell-to-cell distances between tumor-infiltrating inflammatory cells have the potential to distinguish functionally active from suppressed inflammatory cells (2016) Nagl S, Haas M, Lahmer G, Buettner-Herold M, Grabenbauer G, Fietkau R, Distel L Journal article Towards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value Changes (2015) Newe A, Wimmer S, Neubert A, Becker L, Prokosch HU, Beckmann M, Fietkau R, et al. Journal article Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial (2015) Roedel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, et al. Journal article Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: What are the best predictors of remission and prognosis? (2015) Semrau S, Haderlein M, Schmidt D, Lell M, Wolf W, Waldfahrer F, Uder M, et al. Journal article Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells (2015) Hecht M, Erber S, Harrer T, Klinker H, Roth T, Parsch H, Fiebig N, et al. Journal article Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial (2015) Specht HM, Ahrens N, Blankenstein C, Duell T, Fietkau R, Gaipl U, Guenther C, et al. Journal article